| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.2M | -36.1% |
| Cost of Revenue | $889K | -42.3% |
| Gross Profit | $287K | -4.0% |
| R&D Expense | $1.7M | -4.3% |
| SG&A Expense | $4.8M | -19.1% |
| Operating Income | -$8.2M | +18.4% |
| Pre-tax Income | -$8.2M | +18.3% |
| Net Income | -$8.2M | +18.3% |
| EPS (Basic) | -$10.40 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.4M | -3.5% |
| Accounts Receivable | $174K | +97.7% |
| Inventory | $756K | -12.4% |
| Current Assets | $4.7M | -12.0% |
| Total Assets | $5.2M | -11.9% |
| Current Liabilities | $1.4M | -24.6% |
| Total Liabilities | $1.6M | -29.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.5M | +4.6% |
| Capital Expenditures | $118K | +972.7% |
| Investing Cash Flow | -$118K | -972.7% |
| Financing Cash Flow | $8.5M | +1711.2% |
| Free Cash Flow | -$8.6M | +3.4% |
| -900.0% |
| EPS (Diluted) | -$10.40 | -900.0% |
| Stockholders' Equity |
| $3.6M |
| -1.4% |